Lyme vaccineValnevas Lyme vaccine trial completes recruitmentPfizer and Valneva announced the completion of enrolment in Phase 3 VALOR trial for Lyme borreliosis vaccine candidate VLA15. More then 9,000 participants were enrolled. more ➔
cancerUnveiling prostate cancer’s Achilles’ heelResearchers uncover a potential strategy to target and inhibit the androgen receptor in aggressive prostate cancer by exploiting protein droplets. more ➔
Funding$30m for genetic medicine advancementsEligo Bioscience secures $30m in series B funding, advancing its innovative gene-editing solutions targeting diseases linked to bacterial genes within the human microbiome. more ➔
ADCTakeover in ADC space: Abbvie snags ImmunoGenAbbVie buys ImmunoGen in US$10 billion deal, gains access to ADC for ovarian cancer. The ADC space gets hotter and hotter. more ➔
financingAI protein specialist Cradle raises US$24m in Series A financingGenerative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led by Index Ventures w more ➔
CGTRepairing MS-caused damage with stem cellsBritish and Italian researchers have demostrated promising results in patients with progressive multiple sclerosis through stem cell transplantation into the brain. more ➔
COPDBreakthrough in COPD treatmentFrench Sanofi SA’s second Phase III trial of duplimab demonstrated a 34% reduction in exacerbations and significant lung function improvements. more ➔
ObesityNovo Nordisk invests €2.1bn in production expansionIn the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is expanding production in Europe. more ➔
financingQuotient Therapeutics kicks-off with US$50m financingFlagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger … more ➔
financingSolar Foods raises €8m in Series B financingFinnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant. more ➔
